TJY-16 administered intraperitoneally once per day for 10 days in a dose 24 mg/kg in the nude mice with xenograft tumor model of U87 glioma cells effectively inhibited tumor growth and induced caspase-3 activation. The gene discussed is CASP3; the disease is central nervous system cancer.